This document has not been cited yet.

1. Act to promote competition in the statutory health insurance (in German). SHI Competition Promotion Act. 26.03.2007. Federal Law Gazette 2007; Part 1(11): 378–473.
   Paper not yet in RePEc: Add citation now
   

2. Bekkering, G., Kleijnen, J.: Procedures and methods of benefit assessments for medicines in Germany. Eur J Health Econ 9, 5–29 (2008).

3. Bekkering, G.E., Kleijnen, J.: Procedures and methods of benefit assessments for medicines in Germany (in German). Dtsch Med Wochenschr 133, S225–S246 (2008).
   Paper not yet in RePEc: Add citation now
   
4. Bertelsmann, H., Roters, D., Bronner, D.: Benefits and benefits assessment: the principles of evidence-based medicine and health technology assessment as a decisional basis for the federal joint committee (in German). Z Arztl Fortbild Qualitatssich 101, 455–462 (2007).
   Paper not yet in RePEc: Add citation now
   
5. Eisenberg, J.M.: Globalize the evidence, localize the decision: evidence-based medicine and international diversity. Health Aff (Millwood) 21, 166–168 (2000).
   Paper not yet in RePEc: Add citation now
   
6. Institute for Quality and Efficiency in Health Care.: Stem cell transplantation in adults with acute lymphoblastic leukaemia (all) or acute myeloid leukaemia (AML) (in German). Final report N05-03A IQWIG, Cologne. http://www.iqwig.de/download/N05-03A_Abschlussbericht_Stammzell transplantation_be_ALL_und_AML.pdf (2007).
   Paper not yet in RePEc: Add citation now
   
7. Liberati, A., Sheldon, T.A., Banta, H.D.: EUR-ASSESS project subgroup report on methodology: methodological guidance for the conduct of health technology assessment. Int J Technol Assess Health Care 13, 186–219 (1997).
   Paper not yet in RePEc: Add citation now
   
8. Norris, S.L., Atkins, D.: Challenges in using nonrandomized studies in systematic reviews of treatment interventions. Ann Intern Med 142, 1112–1119 (2005).
   Paper not yet in RePEc: Add citation now
   
9. Royle, P., Waugh, N.: Literature searching for clinical and cost-effectiveness studies used in health technology assessment reports carried out for the National Institute for Clinical Excellence appraisal system. Health Technol Assess 7, 51 (2003).
   Paper not yet in RePEc: Add citation now
   
10. Windeler J.: The meaning of randomised clinical trials with relevant outcomes for benefit assessments (in German). In: Health Research Council (GFR) of the Federal Ministry of Education and Research (ed.) Definition of Terms and Introduction—Documentation of the First Joint workshop of GFR and IQWiG, 04 September 2007, pp. 26–31. Bonn: Health Research Council, Berlin (2007).
    Paper not yet in RePEc: Add citation now
    

1. A Systematic Review of Cost-Sharing Strategies Used within Publicly-Funded Drug Plans in Member Countries of the Organisation for Economic Co-Operation and Development. (2014). Husereau, Don ; Harris, Anthony ; Lorenzetti, Diane ; Donaldson, Cam ; Manns, Braden ; Klarenbach, Scott ; Blom, Marja ; Barnieh, Lianne ; Clement, Fiona.
   In: PLOS ONE.
   RePEc:plo:pone00:0090434.

   Full description at Econpapers || Download paper

2. A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention. (2011). Leidl, Reiner ; Blankart, Katharina ; Rogowski, Wolf H. ; Fischer, Katharina E..
   In: Health Policy.
   RePEc:eee:hepoli:v:101:y:2011:i:3:p:290-299.

   Full description at Econpapers || Download paper

3. Procedures and methods of benefit assessments for medicines in Germany: give the child a name. (2009). Falck-Ytter, Yngve ; Kunz, Regina ; Santesso, Nancy ; Schunemann, Holger.
   In: The European Journal of Health Economics.
   RePEc:spr:eujhec:v:10:y:2009:i:2:p:237-238.

   Full description at Econpapers || Download paper

4. Response to the expertise: Procedures and methods of benefit assessments for medicines in Germany, by Geertruida E. Bekkering and Jos Kleijnen. (2009). Lange, Stefan ; Koch, Klaus .
   In: The European Journal of Health Economics.
   RePEc:spr:eujhec:v:10:y:2009:i:2:p:233-236.

   Full description at Econpapers || Download paper

Report date: 2025-10-06 15:57:23 || Missing content? Let us know